In the fall 2013 issue of Caspian Journal of Internal Medicine, an interesting article entitled “The association between CD166 detection rate and clinicopathologic parameters of patients with colorectal cancer” was reported by Shafaei et al. (1). Here, ALCAM is linked to colorectal cancer.